Piedmont Heart Institute Napa Valley Cardiology Conference

 

Piedmont Heart Institute Napa Valley Cardiology Conference
Avatar

The Stroke Prevention War: DOAC vs Warfarin vs LAA Device Closure

By Piedmont Heart Institute Napa Valley Cardiology Conference FEATURING Thomas Deering
By Piedmont Heart Institute Napa Valley Cardiology Conference FEATURING Thomas Deering
0 views
November 15, 2019
Comments 1
Login to view comments. Click here to Login

Featured Video

04:41
AtriCure

LAA Electrical Isolation with AtriClip: Acute Validation With Advanc…

Feat. G. Bisleri

Featured Video

29:23
Philips

Now That We Have Passed the Occluded SFA, What Are the Best Treatmen…

Feat. E. Dippel
2019 Conference
12:44
Piedmont Heart Institute Napa Valley Cardiology Conference

Myocarditis: Top 10 Facts & Fallacies

13:15
Piedmont Heart Institute Napa Valley Cardiology Conference

Best Treatment for Critical Limb Ischemia?

Feat. A. Klein
16:28
Piedmont Heart Institute Napa Valley Cardiology Conference

The Stroke Prevention War: DOAC vs Warfarin vs LAA Device Closure

Feat. T. Deering
15:31
Piedmont Heart Institute Napa Valley Cardiology Conference

Challenges with Tricuspid Regurgitation

Feat. V. Bapat
16:40
Piedmont Heart Institute Napa Valley Cardiology Conference

Stress Testing for CAD in 2020: Is There Any Clarity?

22:34
Piedmont Heart Institute Napa Valley Cardiology Conference

Next Steps for Renal Denervation Therapy

Feat. D. Kandzari
20:24
Piedmont Heart Institute Napa Valley Cardiology Conference

Long-term Dual Antiplatelet Therapy After PCI

Feat. P. Kaul
17:01
Piedmont Heart Institute Napa Valley Cardiology Conference

MitraClip in Heart Failure

Feat. V. Rajagopal
15:33
Piedmont Heart Institute Napa Valley Cardiology Conference

CV Risk Predictors: Triglycerides

Feat. J. Mcalister
17:07
Piedmont Heart Institute Napa Valley Cardiology Conference

AF Ablation Post CABANA: What Should Clinicians Do?

Feat. T. Deering
16:38
Piedmont Heart Institute Napa Valley Cardiology Conference

10 Key Points for Cardiovascular Risk Assessment

Feat. K. Watson
17:04
Piedmont Heart Institute Napa Valley Cardiology Conference

Hypertension Guidelines: Do We Have Concensus or Dissensus?

Feat. R. Chazal
18:40
Piedmont Heart Institute Napa Valley Cardiology Conference

Diabetes and Coronary Artery Disease: How do We Risk Stratify?

Feat. R. Hendel
08:43
Piedmont Heart Institute Napa Valley Cardiology Conference

Revisiting Aortic Stenosis

Feat. P. Sorajja
16:19
Piedmont Heart Institute Napa Valley Cardiology Conference

PCI vs CABG for Diabetes and Cardiovascular Risk

Feat. J. Woo